A group of natural compounds attracting attention for their anti-aging potential has a dark side. New research shows how a ...

A receptor involved in normal physiological processes may also drive breast cancer growth when overexpressed.

More than 200 metabolic enzymes, many of which are normally tasked with producing energy in the mitochondria, are also found ...

Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) (stock code: 7427) announced that its independently developed novel epigenetic immunoactivator GNTbm-38, with global rights for cancer ...

A newly discovered cancer trick that weakens immunotherapy may be stopped by everyday statins.

The team is led by Leanne Li of The Francis Crick Institute in London, England. Her research combines cancer biology and neuroscience to investigate how cancer communicates with peripheral nerves ...

Scientists have identified a crucial molecular switch that decides whether pancreatic cancer cells resist chemotherapy or respond to it. The key player, a gene called GATA6, keeps tumours in a more ...

Polyamines—natural molecules found in every living cell—have become stars in the longevity world for their ability to boost cellular cleanup and support healthy aging. But there’s a dark twist: high ...

Chronic inflammation and oxidative stress contribute to accelerated biological aging and increased skin cancer risk. Proinflammatory and pro-oxidative diets are associated with higher skin cancer risk ...

I disagree with the anti-immigrant, anti-feminist, bitterly reactionary right-wing pundit Matt Walsh about basically everything, so I was surprised to come across a post of his that precisely sums up ...

Despite decades of progress in treating primary tumors, metastasis remains the final frontier and the central challenge in oncology. At late stages of cancer progression, primary localized tumors may ...

This discussion explores how tislelizumab’s unique Fc-region engineering may influence its activity in gastric cancer, particularly in patients with peritoneal metastases. Tislelizumab is designed to ...